The LPS receptor, CD14 in experimental autoimmune encephalomyelitis and multiple sclerosis

Cellular Physiology and Biochemistry

Volumn 17, Issue 3-4, 2006, Pages 167-172

  Walter, Silke ^a   Doering, Axinia ^b   Letiembre, Maryse ^c   Liu, Yang ^a   Hao, Wenlin ^a   Diem, Ricarda ^c   Bernreuther, Christian ^d   Glatzel, Markus ^d   Engelhardt, Britta ^b   Fassbender, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoimmunity; CD14; EAE; Experimental autoimmune encephalomyelitis; Innate immunity; LPS receptor; Multiple sclerosis

Indexed keywords

CD14 ANTIGEN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BIOPSY; CLINICAL FEATURE; CONTROLLED STUDY; DEFENSE MECHANISM; FEMALE; IMMUNOREACTIVITY; IN VIVO STUDY; INNATE IMMUNITY; LEUKOCYTE ACTIVATION; LYMPHOCYTIC INFILTRATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPECIES COMPARISON; SYMPTOM;

ANIMALIA;

EID: 33645006492     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092078     Document Type: Article

References (30)

1. Lassmann H: Neuropathology in multiple sclerosis: new concepts. Mult Scler 1998;4:93-98.
2. Prat A, Antel J: Pathogenesis of multiple sclerosis. Curr Opin Neurol 2005;18:225-230.
3. Sospedra M, Martin R: Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747.
4. Hemmer B, Archelos JJ, Hartung HP: New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 2002;3:291-301.
5. Waldner H, Collins M, Kuchroo VK: Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 2004;113:990-997.
6. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, Bonder C, James WG, Robbins SM, Kubes P: TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 2004;173:7070-7077.
7. Pasare C, Medzhitov R: Control of B-cell responses by Toll-like receptors. Nature 2005;438:364-368.
8. Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Lebeau MM: The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988;239:497-500.
9. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
10. Golenbock DT, Liu Y, Millham FH, Freeman MW, Zoeller RA: Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial exdotoxin. J Biol Chem 1993;268:22055-22059.
11. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995;13:437-457.
12. Zekki H, Feinstein DL, Rivest S: The clinical course of experimental autoimmune encephalomyelitis is associated with a profound and sustained transcriptional activation of the genes encoding toll-like receptor 2 and CD14 in the mouse CNS. Brain Pathol 2002;12:308-319.
13. Fassbender K, Walter S, Kuhl S, Landmann R, Ishii K, Bertsch T, Stalder AK, Muehlhauser F, Liu Y, Ulmer AJ, Rivest S, Lentschat A, Gulbins E, Jucker M, Staufenbiel M, Brechtel K, Walter J, Multhaup G, Penke B, Adachi Y, Hartmann T, Beyreuther K: The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J 2004;18:203-205.
14. Engelhardt B, Vestweber D, Hallmann R, Schulz M: E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis. Blood 1997;90:4459-4472.
15. Fassbender K, Ragoschke A, Rossol S, Schwartz A, Mielke O, Paulig A, Hennerici M: Increased release of interleukin-12p40 in MS: association with intracerebral inflammation. Neurology 1998;51:753-758.
16. Kaisho T, Akira S: Bug detectors. Nature 2001;414:701-703.
17. Beutler B, Poltorak A: Sepsis and evolution of the innate immune response. Crit Care Med 2001;29:S2-6.
18. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388:394-397.
19. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM: CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001;44:13-20.
20. Eisenbarth SC, Cassel S, Bottomly K: Understanding asthma pathogenesis: linking innate and adaptive immunity. Curr Opin Paediatr 2004;16:659-666.
21. Rose B, Herder C, Loffler H, Kolb H, Martin S: Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents. J Leukoc Biol 2004;75:624-630.
22. Park Y, Park S, Yoo E, Kim D, Shin H: Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. Ann NY Acad Sci 2004;1037:170-174.
23. McColl SR, Staykova MA, Wozniak A, Fordham S, Bruce J, Willenborg DO: Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol 1998;161:6421-6426.
24. Buckle AM, Jayaram Y, Hogg N: Colony-stimulating factors and interferon-gamma differentially affect cell surface molecules shared by monocytes and neutrophils. Clin Exp Immunol 1990;81:339-345.
25. Yee J, Christou NV: Neutrophil priming by lipopolysaccharide involves heterogeneity in calcium-mediated signal transduction. Studies using fluo-3 and flow cytometry. J Immunol 1993;150:1988-1997.
26. Hattar K, van Burck S, Bickenbach A, Grandel U, Maus U, Lohmeyer J, Csernok E, Hartung T, Seeger W, Grimminger F, Sibelius U: Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation. J Leukoc Biol 2005;78:992-1000.
27. Echchannaoui H, Frei K, Letiembre M, Strieter RM, Adachi Y, Landmann R: CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration and early death in pneumococcal infection. J Leukoc Biol 2005;78:705-715.
28. Pasare C, Medzhitov : Toll-dependent control mechanisms of CD4 T cell activation. Immunity 2004;21:733-741.
29. Higgins SC, Lavelle EC, McCann C, Keogh B, McNeela E, Byrne P, O'Gorman B, Jarnicki A, McGuirk P, Mills KH: Toll-like receptor4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistence to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 2003;171:3119-3127.
30. Brettschneider J, Ecker D, Bitsch A, Bahner D, Bogumil T, Dressel A, Elitok E, Kitze B, Poser S, Weber F, Tumani H: The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-lb. J Neuroimmunol. 2002;133:93-197.